Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection
The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Impaired APC functions may play important roles in chronicity of hepatitis C virus (HCV) and HIV infections. To investigate the separate and combined effects of HCV and HIV infection on immature dendritic cells (DCs), we evaluated myeloid-derived DC (MDC) and plasmacytoid-derived DC (PDC) frequencies and functions, measured by Toll-like receptor ligand-induced IFN-α and IL-12, in healthy controls and subjects with chronic HCV, HIV, and HCV-HIV infection. To evaluate the relation between innate and adaptive immunity, we measured HCV-specific IFN-γ-producing T cell frequency. MDC frequencies tended to be reduced in HIV infection (1.8-fold), while PDC frequencies were minimally reduced in HCV infection (1.4-fold). In contrast, a striking reduction in non-PDC-associated IFN-α production was observed in HIV-infected subjects (17-fold), while PDC-associated IFN-α production was markedly reduced in HCV-infected subjects (20-fold). Both non-PDC and PDC functions were impaired in HCV-HIV coinfection. MDC-associated IL-12 production was markedly reduced in both HCV and HIV-infected subjects (over 10-fold). Functional defects were attenuated with slowly progressive HIV infection. The proportion of subjects with HCV-specific T cell responses, and the number of Ags recognized were reduced in HCV-HIV subjects as compared with HCV singly infected subjects. A positive association was observed between MDC-associated IL-12 production and HCV-specific T cell frequency in HCV-infected subjects. These results indicate that immature DC function is dysregulated in HIV and HCV infections, but differentially, and that these defects are attenuated in slowly progressive HIV infection. These selectively different impairments may contribute to the reduced adaptive immune response to HCV in HCV-HIV coinfection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Sallusto, F., & Lanzavecchia, A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.4.1109 · Cited by 5,129 · cited 1×
“Immature DC are efficient at Ag uptake (16).”
BackgroundLauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Trinchieri, G. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.001343 · Cited by 2,399
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293 · cited 2×
“PBMC that lack lineage marker expression (CD3, CD14, CD16, CD19, CD20, and CD56) (Dendritic Cell Bundle kit; BD Biosciences, Mountain View, CA), express HLA DR, and express CD11c were identified as MDC; while PBMC that lack lineage marker expression, express HLA DR, and express CD123 were identified as PDC (15, 21, 22…”
BackgroundReciprocal Control of T Helper Cell and Dendritic Cell Differentiation
Rissoan, M.-C., Soumelis, V., Kadowaki, N., Grouard, G., Briere, F., Malefyt, R. D. W., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.283.5405.1183 · Cited by 1,846 · cited 3×
“Initially, MDC and PDC were thought to prime primarily type 1 and type 2 T cell responses, respectively (21).”
BackgroundGenetic organization and diversity of the hepatitis C virus.
Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., & Barr, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2451 · Cited by 1,716
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269 · cited 1×
“Additionally, effector dysfunction of HCV-reactive T cells has been proposed to contribute to the frequent persistence of HCV infection (10, 11).”
BackgroundLiver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., et al. (1999) · Hepatology · doi:10.1002/hep.510300409 · Cited by 1,219
Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells
Langenkamp, A., Messi, M., Lanzavecchia, A., & Sallusto, F. (2000) · Nature Immunology · doi:10.1038/79758 · Cited by 1,143 · cited 1×
“However, subsequent data suggest that function (priming of type 1 vs type 2 responses) may vary with time between Ag exposure and presentation (24), and that PDC are capable of priming type 1 responses in an IL-12 and IFN- -dependent fashion (18).”
BackgroundGraham, C. S., Baden, L. R., Yu, E., Mrus, J. M., Carnie, J., Heeren, T., & Koziel, M. J. (2001) · Clinical Infectious Diseases · doi:10.1086/321909 · Cited by 974
Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization
Cella, M., Facchetti, F., Lanzavecchia, A., & Colonna, M. (2000) · Nature Immunology · doi:10.1038/79747 · Cited by 793 · cited 1×
“However, subsequent data suggest that function (priming of type 1 vs type 2 responses) may vary with time between Ag exposure and presentation (24), and that PDC are capable of priming type 1 responses in an IL-12 and IFN- -dependent fashion (18).”
BackgroundAhmad-Nejad, P., Häcker, H., Rutz, M., Bauer, S., Vabulas, R. M., & Wagner, H. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200207)32:7<1958::aid-immu1958>3.0.co;2-u · Cited by 717 · cited 2×
“Both poly(I:C) and CpG have been previously described to stimulate DC populations via TLR3 and TLR9, respectively (15, 52, 53).”
BackgroundInduction of T H 1 and T H 2 Immunity in Neonatal Mice
Forsthuber, T., Yip, H. C., & Lehmann, P. V. (1996) · Science · doi:10.1126/science.271.5256.1728 · Cited by 681
Self-citationWedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634 · cited 1×
“Consistent with this impairment in allostimulatory function are the findings that HCV-infected individuals have an impaired response to new antigenic stimulation with hepatitis A, hepatitis B, and influenza vaccinations (33–35), while responses to recall Ags are unimpaired (10, 13, 14, 36).”
BackgroundEstimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620 · cited 1×
“4 These individuals are at increased risk of developing cirrhosis, liver failure, and hepatocellular carcinoma (1, 2).”
BackgroundViral infection switches non-plasmacytoid dendritic cells into high interferon producers
Diebold, S. S., Montoya, M., Unger, H., Alexopoulou, L., Roy, P., Haswell, L. E., Al-Shamkhani, A., Flavell, R., Borrow, P., & Sousa, C. R. E. (2003) · Nature · doi:10.1038/nature01783 · Cited by 582 · cited 3×
“However, other DC subtypes are also capable of dominant IFNsecretion during viral infection (23).”
BackgroundSustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C Virus
Gruener, N. H., Lechner, F., Jung, M.-C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5550-5558.2001 · Cited by 495 · cited 2×
“Consistent with this impairment in allostimulatory function are the findings that HCV-infected individuals have an impaired response to new antigenic stimulation with hepatitis A, hepatitis B, and influenza vaccinations (33–35), while responses to recall Ags are unimpaired (10, 13, 14, 36).”
BackgroundDendritic cell ontogeny: A human dendritic cell lineage of myeloid origin
Olweus, J., BitMansour, A., Warnke, R., Thompson, P. A., Carballido, J., Picker, L. J., & Lund-Johansen, F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12551 · Cited by 470 · cited 1×
“Notably, there are likely multiple myeloid-derived APC subsets (45, 46), and a small subset of CD16-expressing MDC that may not be as efficient as other MDC subsets in accessory function has previously been described (46, 47).”
BackgroundBenhamou, Y., Di Martino, V., Bochet, M., Colombet, G., Thibault, V., Liou, A., Katlama, C., & Poynard, T. (2001) · Hepatology · doi:10.1053/jhep.2001.26517 · Cited by 424
Impaired interleukin 12 production in human immunodeficiency virus-infected patients.
Chehimi, J., Starr, S. E., Frank, I., D'Andrea, A., Ma, X., MacGregor, R. R., Sennelier, J., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1361 · Cited by 419 · cited 1×
“In addition to an IFN- -producing deficit, APC from HIV-infected subjects are reduced in IL-12-producing function (28, 29).”
BackgroundImpaired allostimulatory function of dendritic cells in chronic hepatitis C infection
Bain, C., Fatmi, A., Zoulim, F., Zarski, J.-P., Trépo, C., & Inchauspé, G. (2001) · Gastroenterology · doi:10.1053/gast.2001.21212 · Cited by 410 · cited 1×
“cause of impaired allostimulatory function of these cells (31).”
BackgroundDepletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients
Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A., & Liu, Y.-J. (2001) · Blood · doi:10.1182/blood.v98.4.906 · Cited by 398 · cited 3×
“this function in the control of HIV (25, 27).”
BackgroundThe instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics
Lanzavecchia, A., & Sallusto, F. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00218-1 · Cited by 387 · cited 3×
“PBMC that lack lineage marker expression (CD3, CD14, CD16, CD19, CD20, and CD56) (Dendritic Cell Bundle kit; BD Biosciences, Mountain View, CA), express HLA DR, and express CD11c were identified as MDC; while PBMC that lack lineage marker expression, express HLA DR, and express CD123 were identified as PDC (15, 21, 22…”
BackgroundThe Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
Kanto, T., Hayashi, N., Takehara, T., Tatsumi, T., Kuzushita, N., Ito, A., Sasaki, Y., Kasahara, A., & Hori, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5584 · Cited by 356 · cited 1×
“In one study, this reduced allostimulatory capacity was associated with reduced IFN- secretion in mixed lymphocyte reaction supernatants and reduced LPS-induced IL-12-secreting capacity (32).”
BackgroundChehimi, J., Campbell, D. E., Azzoni, L., Bacheller, D., Papasavvas, E., Jerandi, G., Mounzer, K., Kostman, J., Trinchieri, G., & Montaner, L. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4796 · Cited by 344 · cited 2×
“In one study, MDC number was reduced in HIV-infected subjects with higher plasma viral levels ( 5000 copies/ml), and MDC number was inversely associated with plasma HIV levels, again suggesting the potential importance of MDC number in the control of HIV (26).”
BackgroundMonga, H. K., Rodriguez‐Barradas, M. C., Breaux, K., Khattak, K., Troisi, C. L., Velez, M., & Yoffe, B. (2001) · Clinical Infectious Diseases · doi:10.1086/321819 · Cited by 321 · cited 1×
“Additionally, HCV infection has emerged as a cause of increased morbidity and mortality in HIV-infected individuals (6, 7).”
BackgroundAuffermann-Gretzinger, S., Keeffe, E. B., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.10.3171 · Cited by 304
Dobrovolskaia, M. A., Medvedev, A. E., Thomas, K. E., Cuesta, N., Toshchakov, V., Ren, T., Cody, M. J., Michalek, S. M., Rice, N. R., & Vogel, S. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.508 · Cited by 300
Loré, K., Betts, M. R., Brenchley, J. M., Kuruppu, J., Khojasteh, S., Perfetto, S., Roederer, M., Seder, R. A., & Koup, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4320 · Cited by 291
Cousens, L. P., Peterson, R., Hsu, S., Dorner, A., Altman, J. D., Ahmed, R., & Biron, C. A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1315 · Cited by 290 · cited 1×
“Mature DC, in addition to expressing necessary costimulatory signals, also secrete IFNand IL-12, which facilitate the effective priming of human type 1 cytokine-producing T cells (15, 17–19) and resistance to viral infection (20).”
BackgroundKadowaki, N., Antonenko, S., & Liu, Y.-J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2291 · Cited by 280 · cited 3×
“literature (23, 48) in that it is dependent on non-PDC populations.”
BackgroundMethodSafety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
Keeffe, E. B., Iwarson, S., McMahon, B. J., Lindsay, K. L., Koff, R. S., Manns, M., Baumgarten, R., Wiese, M., Fourneau, M., Safary, A., et al. (1998) · Hepatology · doi:10.1002/hep.510270336 · Cited by 268
Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Do, T., Romics, L., Mandrekar, P., Zapp, M., & Szabo, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5615 · Cited by 255
Feldman, S., Stein, D., Amrute, S., Denny, T., Garcia, Z., Kloser, P., Sun, Y., Megjugorac, N., & Fitzgerald-Bocarsly, P. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5111 · Cited by 250 · cited 3×
“Additionally, MDC numbers have been found to be reduced in HIV-infected subjects (25, 26).”
BackgroundThomas, R., & Lipsky, P. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4016 · Cited by 241 · cited 1×
“Notably, there are likely multiple myeloid-derived APC subsets (45, 46), and a small subset of CD16-expressing MDC that may not be as efficient as other MDC subsets in accessory function has previously been described (46, 47).”
BackgroundPatterson, S., Rae, A., Hockey, N., Gilmour, J., & Gotch, F. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6710-6713.2001 · Cited by 195 · cited 1×
“Similarly, direct infection of DC by HIV may cause a similar impairment (57).”
BackgroundWong, D. K. H., Dudley, D. D., Afdhal, N. H., Dienstag, J., Rice, C. M., Wang, L., Houghton, M., Walker, B. D., & Koziel, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1479 · Cited by 185
Single-Cytokine-Producing CD4 Memory Cells Predominate in Type 1 and Type 2 Immunity
Karulin, A. Y., Hesse, M. D., Tary-Lehmann, M., & Lehmann, P. V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1862 · Cited by 174
Self-citationAbnormal Priming of CD4+T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins
Sarobe, P., Lasarte, J. J., Casares, N., López-Díaz de Cerio, A., Baixeras, E., Labarga, P., García, N., Borrás-Cuesta, F., & Prieto, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5062-5070.2002 · Cited by 166 · cited 1×
“support of this is the observation that when DC from normal donors are transduced with the HCV gene containing adenovirus constructs, the ability to stimulate CD4 cells is impaired, resulting in incomplete activation (56).”
BackgroundDecreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C
Wiedmann, M., Liebert, U. G., Oesen, U., Porst, H., Wiese, M., Schroeder, S., Halm, U., Mössner, J., & Berr, F. (2000) · Hepatology · doi:10.1002/hep.510310134 · Cited by 163
Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors
Scognamiglio, P., Accapezzato, D., Casciaro, M. A., Cacciani, A., Artini, M., Bruno, G., Chircu, M. L., Sidney, J., Southwood, S., Abrignani, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6681 · Cited by 161
Cacoub, P., Geffray, L., Rosenthal, É., Perronne, C., Veyssier, P., Raguin, G., & for the Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases (GERMIVIC Study Group) (2001) · Clinical Infectious Diseases · doi:10.1086/319747 · Cited by 138
Chougnet, C. A., Wynn, T. A., Clerici, M., LANDAY, A. L., Kessler, H. A., Rusnak, J. M., MELCHER, G. P., Sher, A., & Shearer, G. M. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.1.46 · Cited by 134
Schmidt, C. S., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5521 · Cited by 126
The role of immune responses in the pathogenesis of hepatitis C virus infection
Koziel, M. J. (1997) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1997.tb00178.x · Cited by 124 · cited 1×
“The T cell response directed at HCV-derived Ags in the infected host is thought to be important in the pathogenesis of HCV-mediated disease, associated both with favorable clinical outcome as well as organ damage (8, 9).”
BackgroundChang, K., Gruener, N. H., Southwood, S., Sidney, J., Pape, G. R., Chisari, F. V., & Sette, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.1156 · Cited by 116
Lauer, G. M., Nguyen, T. N., Day, C. L., Robbins, G. K., Flynn, T., McGowan, K., Rosenberg, E. S., Lucas, M., Klenerman, P., Chung, R. T., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.6.2817-2826.2002 · Cited by 116
Almeida, J., Bueno, C., Alguero, M. C., Sánchez, M. L., de Santiago, M., Escribano, L., Dı́az-Agustı́n, B., Vaquero, J. M., Laso, F. J., Miguel, J. F. S., et al. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5072 · Cited by 94 · cited 1×
“Notably, there are likely multiple myeloid-derived APC subsets (45, 46), and a small subset of CD16-expressing MDC that may not be as efficient as other MDC subsets in accessory function has previously been described (46, 47).”
BackgroundWong, D., Dudley, D. D., Dohrenwend, P. B., Lauer, G. M., Chung, R. T., Thomas, D. L., & Walker, B. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1229-1235.2001 · Cited by 83
Valdez, H., Anthony, D. D., Farukhi, F., Patki, A. H., Salkowitz, J. R., Heeger, P. S., Peterson, D. L., Post, A. B., Asaad, R. J., & Lederman, M. M. (2000) · AIDS · doi:10.1097/00002030-200010200-00004 · Cited by 70 · cited 3×
“Consistent with this impairment in allostimulatory function are the findings that HCV-infected individuals have an impaired response to new antigenic stimulation with hepatitis A, hepatitis B, and influenza vaccinations (33–35), while responses to recall Ags are unimpaired (10, 13, 14, 36).”
BackgroundResultSelf-citationHIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens
Valdez, H., Carlson, N. L., Post, A. B., Asaad, R. J., Heeger, P. S., Lederman, M. M., Lehmann, P., & Anthony, D. D. (2002) · AIDS · doi:10.1097/00002030-200205240-00004 · Cited by 55 · cited 4×
“04), extending upon our previously published finding where a nonsignificant trend existed (14).”
BackgroundResultSelf-citationUrbani, S., Uggeri, J., Matsuura, Y., Miyamura, T., Penna, A., Boni, C., & Ferrari, C. I. (2001) · Hepatology · doi:10.1053/jhep.2001.25091 · Cited by 50
Anthony, D. D., Post, A. B., Valdez, H., Peterson, D. L., Murphy, M., & Heeger, P. S. (2001) · Clinical Immunology · doi:10.1006/clim.2001.5018 · Cited by 43
Self-citationSobao, Y., Tomiyama, H., Nakamura, S., Sekihara, H., Tanaka, K., & Takiguchi, M. (2001) · Hepatology · doi:10.1053/jhep.2001.21164 · Cited by 42
Anthony, D. D., Valdez, H., Post, A. B., Carlson, N. L., Heeger, P. S., & Lehmann, P. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5193 · Cited by 23 · cited 1×
“Sixty one of these 73 peptides have been previously described as a set (41).”
BackgroundSelf-citation
Cited by
Beignon, A.-S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 673
Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., Huebner, R. E., Janoff, E. N., Justice, A. C., Kuritzkes, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590150 · Cited by 539
“Immune dysfunction in HIV-HCV–coinfected patients differs from that associated with chronic HIV or HCV infection alone [148–150], and some comorbidities are more common among coinfected individuals [148].”
Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity
McKenna, K., Beignon, A.-S., & Bhardwaj, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.17-27.2005 · Cited by 394
Lederman, M. M., Calabrese, L., Funderburg, N. T., Clagett, B., Medvik, K., Bonilla, H., Gripshover, B., Salata, R. A., Taege, A., Lisgaris, M., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir507 · Cited by 328
Self-citationPlasmacytoid dendritic cells—virus experts of innate immunity
Barchet, W., Cella, M., & Colonna, M. (2005) · Seminars in Immunology · doi:10.1016/j.smim.2005.05.008 · Cited by 202
Metadata
- Authors
- Anthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V., & Valdez, H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04
- Volume
- 172
- Issue
- 8
- Pages
- 4907-4916
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1500258913
- Cited by
- 165
- References
- 58
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.